Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Phathom Pharmaceuticals (PHAT) Return on Equity (2022 - 2025)

Historic Return on Equity for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to 0.66%.

  • Phathom Pharmaceuticals' Return on Equity fell 9500.0% to 0.66% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.66%, marking a year-over-year decrease of 9500.0%. This contributed to the annual value of 2.05% for FY2024, which is 6800.0% down from last year.
  • Per Phathom Pharmaceuticals' latest filing, its Return on Equity stood at 0.66% for Q3 2025, which was down 9500.0% from 0.89% recorded in Q2 2025.
  • Phathom Pharmaceuticals' Return on Equity's 5-year high stood at 2043.99% during Q3 2023, with a 5-year trough of 0.66% in Q3 2025.
  • In the last 4 years, Phathom Pharmaceuticals' Return on Equity had a median value of 1.92% in 2024 and averaged 172.45%.
  • Its Return on Equity has fluctuated over the past 5 years, first surged by 5500bps in 2023, then tumbled by -20423800bps in 2024.
  • Over the past 4 years, Phathom Pharmaceuticals' Return on Equity (Quarter) stood at 3.9% in 2022, then rose by 14bps to 4.45% in 2023, then plummeted by -66bps to 1.52% in 2024, then crashed by -56bps to 0.66% in 2025.
  • Its last three reported values are 0.66% in Q3 2025, 0.89% for Q2 2025, and 1.17% during Q1 2025.